Construction nearly complete on new injectables plant in Memphis

Construction on a new, $20 million injectables plant in Memphis, Tennessee, is wrapping up.

Construction of the $20 million Plough Center for Sterile Drug Delivery Systems in Memphis, Tennessee, is expected to be completed in the coming weeks.

The 10,000-square-foot injectables facility will be operated by the University of Tennessee Health Science Center (UTHSC) and is located in the Memphis Medical District. It’s expected to employ about 20 people and will be able to produce 50,000 vials per day, or 100,000 to 200,000 syringes, the Daily News in Memphis reported.

The facility is expected to open by the end of the year and will manufacture only liquid medications for injectables.

Cambrex Webinar

Understanding the Importance of Crystallization Processes to Avoid Unnecessary Cost, Risk and Development Delays

Wednesday, May 27, 2020 | 10am ET / 7am PT

A well-developed crystallization process can produce suitable particles that can facilitate consistent filtration, drying and formulation of the API and allow confident and reliable manufacturing of the final drug product, while avoiding unnecessary cost, risk and development delays.

“It will enhance some of the work the college of pharmacy and the pharmaceutical scientists do to get new drugs to market,” Dr. Kennard Brown, UTHSC executive vice chancellor and CEO, told the Daily News.

Suggested Articles

Novavax will shell out $167 million for Czech manufacturer Praha Vaccines in a move to boost production of a COVID-19 vaccine past 1 billion doses.

The FDA knocked Altaire Pharmaceuticals for falsified data and harebrained contraptions at its New York plant in a scathing warning letter.

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.